ALCAR.PA

Carmat

ALCAR.PA, France

Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

https://www.carmatsa.com

Stock Price

€0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
ALCAR.PA
stock
ALCAR.PA

Carmat SA (ALCAR.PA): Earnings Spotlight Amid Market Uncertainty Meyka

Read more →
ALCAR.PA
stock
ALCAR.PA

CARMAT Announces Its Placement in Receivership Procedure Yahoo Finance

Read more →

Showing 2 of 7

Analyst Ratings & Sentiment

(Last Updated 2024-12-31)

Rating:

HOLD

$

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2024-12-31)

Health Score

Price to Book Ratio (P/B)

-

Very Low

-0.04

Low 1

High 3

Return on Equity (ROE)

-

Very High

49.37 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

-59.50 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-479.87 %

Low 5%

High 15%

Investors

* Institutions hold a combined 0.00% of the total shares of Carmat

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.11

Latest Release

Date

2025-09-30

EPS Actual

0

EPS Estimate

-0.13

EPS Difference

0.13

Surprise Percent

100%

Investing Fit Scorecard

(Last Updated 2024-12-31)

Deep Value
Weak Deep Value(2)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Fair GARP(3.5)
Growth
Moderate Growth(3.5)
Momentum
No Momentum(2)
Net Net
Not Undervalued (Net-Net)(1.5)
Quality
Low Quality Business(2.5)
Value
Overpriced(2.5)

Income Statement

(Last Updated 2024-12-31)

Revenue

€ 0

Cost Of Revenue

€ 0

Gross Profit

€ 0

Operating Expenses

€ 0

Operating Income

€ 0

Interest Expense

€ 0

Pretax Income

€ 0

Net Income

€ 0

Income Tax Expense

€ 0

EBITDA

€ 0

Total Other Income Expense Net

€ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2024-12-31)

Cash

0

Short Term Investments

0

Receivables

0

Inventories

0

Total Current Assets

0

Property Plant Equipment

0

Total Assets

0

Payables

0

Short Term Debt

0

Long Term Debt

0

Total Liabilities

0

Equity

0

Trend

Cash Flow

(Last Updated 2024-12-31)

Net Income

0

Depreciation

0

Change In Working Capital

0

Cash From Operations

0

Capital Expenditures

0

Cash From Investing

0

Cash From Financing

0

Net Change In Cash

0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.